Navigation Links
Florida researchers receive JDRF 'Excellence in Clinical Research Award'
Date:6/16/2008

Washington, DC, June 13, 2008 Mary Tyler Moore, the Juvenile Diabetes Research Foundation's international chairman, and her husband, S. Robert Levine, M.D., presented the sixth annual "Excellence in Clinical Research Award" to a team of Florida scientists at JDRF's annual conference today in Washington, DC.

The recipients of this year's prestigious honor are Mark Atkinson, Ph.D., director of the JDRF Gene Therapy Center for Diabetes and Diabetic Complications at the University of Florida and University of Miami; Michael Haller, M.D., a professor of pediatrics and a researcher at the University of Florida; and Desmond Schatz, M.D., medical director of the Diabetes Center of Excellence and associate director of the General Clinical Research Center at the University of Florida.

The three researchers are involved in several innovative JDRF-funded studies to accelerate the development of a cure for type I diabetes, including using umbilical cord blood stem cells as a potential therapy and investigating drug treatments used in tandem to provide immune suppression while boosting the regeneration of insulin-producing cells.

"We are honored to present JDRF's 2008 Excellence in Clinical Research Award to Drs Schatz, Haller and Atkinson. Their willingness to challenge conventional wisdom and consequent ground-breaking work in translating novel scientific insights into new, potentially life-changing therapies and cures represents the sort of leadership we value most. Their pioneering research in the area of preservation and restoration of pancreatic beta cell mass and function in type 1 diabetes has moved us many steps closer to a cure," stated Mary Tyler Moore and S. Robert Levine MD.

Dr. Atkinson has spent 25 years in the field of type 1 diabetes research. An internationally-recognized authority in several research fields and a past JDRF chair for medical science research, his work focuses on disease prediction and prevention, environmental factors in the onset of the disease and the study of gene therapy to cure diabetes and prevent its complications.

Dr. Haller has committed his career to developing safe and effective therapies to prevent and reverse type 1 diabetes. The recipient of several prestigious awards for his work, he is an active investigator in TrialNet Research funded by the National Institute of Health and chairs the Clinical Implementation Committee of the TEDDY study, which focuses on determining the role of environmental factors in the development of diabetes.

Dr. Schatz has been involved in type 1 diabetes research since the 1980s, focusing on prediction, natural history, genetics and prevention of the disease, as well as the management of children and adolescents with type 1 diabetes. The author of more than 170 manuscripts, he is the principal investigator on several JDRF and NIH projects and co-principal investigator on a JDRF-funded project studying the origin and development of type 1 diabetes.

The annual "Excellence in Clinical Research Award" recognizes outstanding scientists who are pursuing research toward finding a cure for type 1 diabetes and its complications. Presented each year at JDRF's conference, it is named for Moore and Levine in honor of their longtime extraordinary efforts and commitment to JDRF's mission to find a cure for diabetes and its complications through the support of research.


'/>"/>

Contact: Jillian Lubarsky
jlubarsky@jdrf.org
212-479-7626
Juvenile Diabetes Research Foundation International
Source:Eurekalert

Related biology news :

1. Palm Beach County wants to establish a Max Planck Institute in Florida
2. New south Florida nursery to focus on staghorn corals
3. ASNTR 15th anniversary meeting to be held May 1-3 in Florida
4. DHS Expands Biometrics-at-Sea Program to the Florida Straits
5. Fecal microorganisms inhabit sandy beaches of Florida
6. Researchers identify proteins involved in new neurodegenerative syndrome
7. Texas researchers and educators head for Antarctica
8. MGH researchers describe new way to identify, evolve novel enzymes
9. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
10. U of MN researchers discover noninvasive diagnostic tool for brain diseases
11. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... 2017 , ... DuPont Pioneer and recently formed CasZyme, a ... a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The goal of ... across all applications. , Under the terms of the agreement, Pioneer will provide ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Wound Market with the addition of its newest module, US Hemostats & Sealants. ... for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
Breaking Biology Technology: